155 related articles for article (PubMed ID: 7639972)
21. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
[TBL] [Abstract][Full Text] [Related]
23. [Secondary prevention of cytomegalovirus retinitis with ganciclovir].
Garweg J; Olszowski W; Knospe V; Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Weitner L; Dietrich M
Ophthalmologe; 1993 Jun; 90(3):267-73. PubMed ID: 8334330
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
Teoh SC; Ou X; Lim TH
Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
[TBL] [Abstract][Full Text] [Related]
25. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
[TBL] [Abstract][Full Text] [Related]
26. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
Lalezari JP; Friedberg DN; Bissett J; Giordano MF; Hardy WD; Drew WL; Hubbard LD; Buhles WC; Stempien MJ; Georgiou P; Jung DT; Robinson CA;
J Clin Virol; 2002 Feb; 24(1-2):67-77. PubMed ID: 11744430
[TBL] [Abstract][Full Text] [Related]
27. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
Duker JS; Robinson M; Anand R; Ashton P
Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
[TBL] [Abstract][Full Text] [Related]
28. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
29. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
30. CMV news.
Posit Aware; 1996; 7(1):5-6. PubMed ID: 11363124
[TBL] [Abstract][Full Text] [Related]
31. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
[TBL] [Abstract][Full Text] [Related]
32. Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.
Perry CM; Davis R
Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):209-28. PubMed ID: 10169672
[TBL] [Abstract][Full Text] [Related]
33. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
34. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy.
Jacobson MA; O'Donnell JJ; Porteous D; Brodie HR; Feigal D; Mills J
Q J Med; 1988 Jun; 67(254):473-86. PubMed ID: 2854894
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
[TBL] [Abstract][Full Text] [Related]
36. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group.
Spector SA; Weingeist T; Pollard RB; Dieterich DT; Samo T; Benson CA; Busch DF; Freeman WR; Montague P; Kaplan HJ
J Infect Dis; 1993 Sep; 168(3):557-63. PubMed ID: 8394858
[TBL] [Abstract][Full Text] [Related]
38. A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
Lalezari J; Lindley J; Walmsley S; Kuppermann B; Fisher M; Friedberg D; Lalonde R; Matheron S; Nieto L; Torriani FJ; Van Syoc R; Sutton MA; Buhles W; Stempien MJ;
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):392-400. PubMed ID: 12138345
[TBL] [Abstract][Full Text] [Related]
39. Update on treatment of CMV retinitis.
Feinberg J
AIDS Clin Care; 1995 Sep; 7(9):71-3, 75, 78. PubMed ID: 11362779
[TBL] [Abstract][Full Text] [Related]
40. Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis.
Piketty C; Bardin C; Gilquin J; Gairard A; Kazatchkine MD; Chast F
Clin Microbiol Infect; 2000 Mar; 6(3):117-20. PubMed ID: 11168085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
